Skip to main content
OpenTrials

Clinical trial condition

Relapsing-Remitting Multiple Sclerosis

Explore clinical trials studying Relapsing-Remitting Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

98 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Relapsing-Remitting Multiple Sclerosis trial results

Completed

Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple Sclerosis

NCT00879658

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Diseases, +16 more
Locations
  • Novartis Investigative Site Cullman, Alabama, United States
  • Novartis Investigative Site San Francisco, California, United States
  • Novartis Investigative Site Centennial, Colorado, United States
  • Novartis Investigative Site Miami, Florida, United States
View all 72 locations
View Trial Details
Completed

Observational Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JC Virus Antibody Negative Participants

NCT01485003

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Homewood, Alabama, United States
  • Research Site Sun City, Arizona, United States
  • Research Site La Jolla, California, United States
  • Research Site Los Angeles, California, United States
View all 44 locations
View Trial Details
Completed

Follow up Study of Patients on Fingolimod Who Were Enrolled in the Original Biobank Study (CFTY720DDE01)

NCT02720107

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Novartis Investigative Site Ostfildern, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Altenholz-Stift, Germany
  • Novartis Investigative Site Aschaffenburg, Germany
  • Novartis Investigative Site Berlin, Germany
View all 26 locations
View Trial Details
Completed

An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)

NCT01838668

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Fakultni nemocnice u sv. Anny v Brne Brno, Czechia
  • Neurospol, s.r.o. Havířov, Czechia
  • Fakultni nemocnice Hradec Kralove Hradec Králové, Czechia
  • Privatni ordinace - neurologie Hradec Králové, Czechia
View all 54 locations
View Trial Details
Completed

A Study of Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)

NCT00882999

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +11 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Phoenix, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tucson, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fullerton, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Denver, Colorado, United States
View all 63 locations
View Trial Details
Completed

Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) (BIIB019) in Participants Who Have Completed Study 205MS202 (NCT00870740) to Treat Relapsing Remitting Multiple Sclerosis

NCT01051349

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Brno, Czechia
  • Research Site Brno, Czechia
  • Research Site Hradec Králové, Czechia
  • Research Site Prague, Czechia
View all 65 locations
View Trial Details

Related conditions